SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-21-000039
Filing Date
2021-12-17
Accepted
2021-12-17 16:16:45
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163977578709580.html 4  
1 FORM 4 wf-form4_163977578709580.xml 4 3979
  Complete submission text file 0001599298-21-000039.txt   5548
Mailing Address MAKY ZANGANEH & ASSOCIATES 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Maky (Reporting) CIK: 0001507650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 211501779

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations